FDA 510(k)
FDA class 2
Substantially Equivalent
🇹🇼 Taiwan
Copioumed AAMI 3 Surgical Gown
K Number: K251860
·
Decision Feb 26, 2026
Classifications
1
FEI Numbers
222
Registration Numbers
222
Same Product Code
294
Applicant Total
2
Review Days
254
Basic Information
- Device Name
- Copioumed AAMI 3 Surgical Gown
- K Number
- K251860
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 878.4040
- Medical Specialty
- General, Plastic Surgery
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Copioumed International, Inc.
- Date Received
- June 17, 2025
- Decision Date
- February 26, 2026
- Product Code
- FYA
- Advisory Committee
- General, Plastic Surgery
- Review Advisory Committee
- HO
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| FYA | Gown, Surgical | FDA class 2 | General, Plastic Surgery |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (FYA), ordered by most recent decision date.
Tuff Cuff Disposable Surgical Gowns AAMI L4 Sterile-Large (ML-L4-STL-DC-L)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
BAÜMER Surgical Gowns (COP01, COP04, COP05, COP10)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Cardinal Health Poly Reinforced Surgical Gown
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Non-sterile Level 3 Surgical Gown (4025); Sterile Level 3 Surgical Gown (M4025); Non-sterile Reinforced Level 4 Surgical Gown (G4025); Reinforced Sterile Level 4 Surgical Gown (GM4025)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Henan Yadu Level 4 Surgical Gowns (Reinforced)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Surgical Gown (Level 3: S, M, L, XL, XXL, XXXL)
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Other Clearances by Copioumed International, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K230135 | Copioumed Chemotherapy Isolation Gown | Oct 4, 2023 | Substantially Equivalent |